देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
METHYLPHENIDATE HYDROCHLORIDE
TEVA CANADA LIMITED
N06BA04
METHYLPHENIDATE
36MG
TABLET (EXTENDED-RELEASE)
METHYLPHENIDATE HYDROCHLORIDE 36MG
ORAL
100/500
Schedule G (CDSA III)
Respiratory and CNS Stimulants
Active ingredient group (AIG) number: 0107548005; AHFS:
CANCELLED POST MARKET
2023-03-21
_ _ PRODUCT MONOGRAPH TEVA-METHYLPHENIDATE ER-C (Methylphenidate Hydrochloride) Extended-release Tablets 18 mg, 27 mg, 36 mg, and 54 mg Teva Standard CNS Stimulant Teva Canada Limited Date of Revision: 30 Novopharm Court December 19, 2019 Toronto, Ontario M1B 2K9 www.tevacanada.com Submission Control No: 233639 C _Teva-Methylphenidate ER-C_ _Page 2 of 50 _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION............................................................... 3 SUMMARY PRODUCT INFORMATION ............................................................................... 3 INDICATIONS AND CLINICAL USE ..................................................................................... 3 CONTRAINDICATIONS .......................................................................................................... 5 WARNINGS AND PRECAUTIONS ......................................................................................... 5 ADVERSE REACTIONS ......................................................................................................... 11 DRUG INTERACTIONS ......................................................................................................... 19 DOSAGE AND ADMINISTRATION ..................................................................................... 20 OVERDOSAGE ....................................................................................................................... 23 ACTION AND CLINICAL PHARMACOLOGY ................................................................... 23 STORAGE AND STABILITY ................................................................................................. 28 DOSAGE FORMS, COMPOSITION AND PACKAGING .................................................... 28 PART II: SCIENTIFIC INFORMATION .................................................................................... 30 PHARMACEUTICAL INFORMATION ................................................................................. 30 CLINICAL TRIALS ..................... पूरा दस्तावेज़ पढ़ें